◂ Announcements

Nov 28, 2016ACQUISITIONUnited States

Navidea sells North American Lymphoseek rights to Cardinal Health in $310M deal

Navidea Biopharmaceuticals signed a definitive asset purchase agreement with Cardinal Health for its Lymphoseek product. Navidea will receive $80 million at closing plus up to $230 million in milestone payments through 2026, with over $20 million guaranteed over the next 3 years.

Value

$310.0M

Status

Announced

ProductsLymphoseek (lymphatic mapping and lymph node biopsy product)

CompaniesNavidea Biopharmaceuticals Cardinal Health acquirer

Sectors#Medical Devices

“Navidea Biopharmaceuticals said today that it inked a definitive asset purchase agreement with Cardinal Health for its Lymphoseek product.”drugdeliverybusiness.com

1 source
drugdeliverybusiness.comNavidea deals NA Lymphoseek rights to Cardinal Health in $310m deal - Drug Delivery BusinessSarah FaulknerNov 28, 2016

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Nov 6, 2026ACQUISITIONUnited States$9.90B
Danaher to acquire Masimo for $9.9 billion
Danaher acquirer Masimo target mdtvnow.com
Nov 5, 2026ACQUISITIONUnited States
Curewell Capital to acquire majority stake in ECA Medical
Curewell Capital acquirer ECA Medical target businesswire.com
Nov 5, 2026ACQUISITIONUnited States$538.0M
ZOLL Medical to acquire Itamar Medical for $538M
Asahi Kasei investor ZOLL Medical Corporation acquirer forpressrelease.com
Nov 4, 2026ACQUISITIONPlano, Texas, United States$2.25M
OSTEONIC acquires controlling stake in FoxEyes for 3 billion won
OSTEONIC FoxEyes target en.edaily.co.kr
Nov 3, 2026ACQUISITIONDeerfield, Illinois, United States
Vantive to divest majority of hemodialysis assets to Rockwell Medical
Vantive Rockwell Medical acquirer prnewswire.com
Nov 2, 2026ACQUISITIONUnited States$40.0M
Ingersoll Rand acquires precision-pump maker IVEK Corporation
Ingersoll Rand acquirer IVEK Corporation target dealroom.co pumpindustry.com worldpumps.com

Loading…